Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 4, 2012

Telormedix, Foamix Win €950K to Develop Foam-Based Skin Cancer Treatment

  • Telormedix and Foamix have been awarded just shy of €950,000 (slightly below $1.2 million) under the EU’s Eurostars program to fund development of a foam-based topical treatment for skin cancer based on Telormedix’s TMX-202 candidate. Researchers at the Charité-Universitätsmedizin Berlin and the German Cancer Research Center (DKFZ) will collaborate on the two-year TOSCA project, which will study the efficacy and safety of the foam formulation using preclinical animal models.

    Swiss firm Telormedix is focused on the development of innate immune system-modulating drugs for treating cancer and autoimmune diseases. TMX-202 is a TLR7-targeted agonist discovered through a collaboration with the University of California, San Diego. The compound is in development for the potential treatment of dermatological cancers, actinic keratosis, and genital warts.

    Telormedix’s lead candidate, TMX-101, is a small molecule in development for the treatment of superficial bladder cancer. The compound is a known immunomodulatory molecule that has previously demonstrated clinical efficacy in oncological and viral diseases.

    Israel-based Foamix is a clinical-stage specialty pharma company exploiting its topical foam and OilGel™ technologies in house and through commercial partnerships for the development of products for dermatology, gynecology, ophthalmology, wounds, and burn applications. The firm’s first product, the foam-based psoriasis treatment, Scytera™, was launched by Promius Pharmaceuticals in the U.S. in 2009.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »